E
Qualigen Therapeutics, Inc. QLGN
$1.97 $0.073.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- -72.28%
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- -72.28%
Cost of Revenue 59.58% -84.48% -152.39% -127.70% -113.33%
Gross Profit -59.58% 84.48% 152.39% 127.70% 117.82%
SG&A Expenses -2.42% -30.98% -46.09% -51.22% -38.75%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -35.39% -52.20% -46.22% -37.57% -33.40%
Operating Income 35.39% 52.20% 46.22% 37.57% 26.45%
Income Before Tax 39.93% 50.66% 42.82% 31.78% 20.05%
Income Tax Expenses 110.00% 550.00% -210.34% -172.41% -86.11%
Earnings from Continuing Operations 39.92% 50.63% 42.89% 31.84% 20.08%
Earnings from Discontinued Operations 69.79% 89.39% 97.78% 87.37% 91.86%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 40.77% 53.35% 54.71% 44.50% 36.13%
EBIT 35.39% 52.20% 46.22% 37.57% 26.45%
EBITDA 59.99% 51.43% 45.43% 37.33% 26.69%
EPS Basic 83.89% 74.56% 69.64% 55.56% 49.09%
Normalized Basic EPS 81.95% 72.96% 65.07% 48.18% 39.35%
EPS Diluted 83.89% 74.56% 69.66% 55.58% 49.11%
Normalized Diluted EPS 81.95% 72.96% 65.07% 48.18% 39.35%
Average Basic Shares Outstanding 554.07% 256.08% 98.03% 31.12% 26.68%
Average Diluted Shares Outstanding 554.07% 256.08% 98.03% 31.12% 26.68%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --